拉苏可斯特醇用于治疗与酒精有关的肝炎
Mitchell Shiffman1, Ben Da2, Aparna Goel3
1Bon Secours Liver Institute, Richmond, VA.
NEJM evidence
|January 28, 2025
概括
拉苏科斯特醇并没有显著降低严重酒精相关性肝炎 (AH) 的90天死亡率或肝移植率. 需要进一步的试验来确定其对AH生存的有效性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 酒精相关性肝炎 (AH) 是一种严重的肝病,没有经批准的治疗方法.
- 拉苏可斯特醇是一种研究中的DNA甲基转移酶抑制剂,向AH.
- 目前的治疗依赖于支持性护理,凸显了对新型治疗剂的需求.
研究的目的:
- 评估larsucosterol在患有严重AH的患者中的疗效和安全性.
- 为了确定拉苏科斯特是否能改善90天的存活率,或减少对肝移植的需要.
- 评估不同剂量的拉苏科斯特醇对临床结果的影响.
主要方法:
- 一个2b期随机对照试验,涉及307名严重AH患者.
- 患者接受了30毫克或90毫克拉苏科斯特醇或安慰剂,并可能获得第二剂量.
- 主要终点是90天死亡率或肝移植率,并对美国患者数据进行了二次分析.
主要成果:
- 该研究没有达到其主要终点;在larsucosterol和安慰剂组之间没有观察到90天死亡率或LT的统计学上显著差异.
- 90天死亡率为安慰剂组的25/103,30毫克拉斯科斯特罗尔的15/102,90毫克拉斯科斯特罗尔的17/102.
- 副作用主要归因于潜在的肝病,没有与larsucosterol治疗相关的显著失衡.
结论:
- 拉苏可斯特醇没有证明对严重AH患者的90天死亡率或肝移植有有益影响.
- 该试验确立了平衡性,这表明需要对拉苏可斯特醇进行进一步的研究,以确定AH的存活率.
- 这些发现强调了治疗严重的AH所面临的挑战,以及对有效疗法的持续研究的需要.
相关概念视频
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Cirrhosis I: Introduction
32
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53


